BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

579 related articles for article (PubMed ID: 29771487)

  • 1. Cancer Cell Membrane-Coated Adjuvant Nanoparticles with Mannose Modification for Effective Anticancer Vaccination.
    Yang R; Xu J; Xu L; Sun X; Chen Q; Zhao Y; Peng R; Liu Z
    ACS Nano; 2018 Jun; 12(6):5121-5129. PubMed ID: 29771487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
    Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
    ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer cell membrane-coated nanoparticles for bimodal imaging-guided photothermal therapy and docetaxel-enhanced immunotherapy against cancer.
    Chen Q; Zhang L; Li L; Tan M; Liu W; Liu S; Xie Z; Zhang W; Wang Z; Cao Y; Shang T; Ran H
    J Nanobiotechnology; 2021 Dec; 19(1):449. PubMed ID: 34952587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationalizing the use of functionalized poly-lactic-co-glycolic acid nanoparticles for dendritic cell-based targeted anticancer therapy.
    Kokate RA; Chaudhary P; Sun X; Thamake SI; Maji S; Chib R; Vishwanatha JK; Jones HP
    Nanomedicine (Lond); 2016; 11(5):479-94. PubMed ID: 26892440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineering ApoE3-incorporated biomimetic nanoparticle for efficient vaccine delivery to dendritic cells via macropinocytosis to enhance cancer immunotherapy.
    Zhou S; Huang Y; Chen Y; Liu S; Xu M; Jiang T; Song Q; Jiang G; Gu X; Gao X; Chen J
    Biomaterials; 2020 Mar; 235():119795. PubMed ID: 32014739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
    Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
    Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3-induced immune response by poly(d,l-lactide-co-glycolide) nanoparticles for dendritic cell-based cancer immunotherapy.
    Han HD; Byeon Y; Kang TH; Jung ID; Lee JW; Shin BC; Lee YJ; Sood AK; Park YM
    Int J Nanomedicine; 2016; 11():5729-5742. PubMed ID: 27843314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective Tumor-Specific Antigen Delivery to Dendritic Cells Using Mannose-Labeled Poly(d, l-lactide-co-glycolide) Nanoparticles for Cancer Immunotherapy.
    Wi TI; Byeon Y; Won JE; Lee JM; Kang TH; Lee JW; Lee YJ; Sood AK; Han HD; Park YM
    J Biomed Nanotechnol; 2020 Feb; 16(2):201-211. PubMed ID: 32252881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEGylated tumor cell membrane vesicles as a new vaccine platform for cancer immunotherapy.
    Ochyl LJ; Bazzill JD; Park C; Xu Y; Kuai R; Moon JJ
    Biomaterials; 2018 Nov; 182():157-166. PubMed ID: 30121425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of antigen and dual agonists by programmed mannose-targeted cationic lipid-hybrid polymersomes for enhanced vaccination.
    Zhu D; Hu C; Fan F; Qin Y; Huang C; Zhang Z; Lu L; Wang H; Sun H; Leng X; Wang C; Kong D; Zhang L
    Biomaterials; 2019 Jun; 206():25-40. PubMed ID: 30925286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
    Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
    Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLGA-particle vaccine carrying TLR3/RIG-I ligand Riboxxim synergizes with immune checkpoint blockade for effective anti-cancer immunotherapy.
    Koerner J; Horvath D; Herrmann VL; MacKerracher A; Gander B; Yagita H; Rohayem J; Groettrup M
    Nat Commun; 2021 May; 12(1):2935. PubMed ID: 34006895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-functional nanocomplex codelivery of Trp2 and R837 to activate melanoma-specific immunity.
    Ji Z; Tan Z; Li M; Tao J; Guan E; Du J; Hu Y
    Int J Pharm; 2020 May; 582():119310. PubMed ID: 32276088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Employing ATP as a New Adjuvant Promotes the Induction of Robust Antitumor Cellular Immunity by a PLGA Nanoparticle Vaccine.
    Zhang Q; Huang W; Yuan M; Li W; Hua L; Yang Z; Gao F; Li S; Ye C; Chen Y; He J; Sun W; Yang X; Bai H; Ma Y
    ACS Appl Mater Interfaces; 2020 Dec; 12(49):54399-54414. PubMed ID: 33215918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polydopamine nanoparticles cross-linked hyaluronic acid photothermal hydrogel with cascading immunoinducible effects for in situ antitumor vaccination.
    Fang Z; Yan Z; Li Z; Yan C; Jia S; Qiu X; Wang Q; Hou H; Wu Y; Du F; Gong A; Zhang M
    Int J Biol Macromol; 2024 Jun; 269(Pt 2):132177. PubMed ID: 38729484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
    Aikins ME; Xu C; Moon JJ
    Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mannosylated polylactic-co-glycolic acid (MN-PLGA) nanoparticles induce potent anti-tumor immunity in murine model of breast cancer.
    Sheikhzadeh S; Delirezh N; Hobbenaghi R
    Biomed Pharmacother; 2021 Oct; 142():111962. PubMed ID: 34358752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetically Engineered Cytomembrane Nanovaccines for Cancer Immunotherapy.
    Pan Y; Wu X; Liu L; Zhao C; Zhang J; Yang S; Pan P; Huang Q; Zhao XZ; Tian R; Rao L
    Adv Healthc Mater; 2024 May; 13(13):e2400068. PubMed ID: 38320299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supramolecular Lipid Nanoparticles Based on Host-Guest Recognition: A New Generation Delivery System of mRNA Vaccines For Cancer Immunotherapy.
    Qi S; Zhang X; Yu X; Jin L; Yang K; Wang Y; Feng Y; Lei J; Mao Z; Yu G
    Adv Mater; 2024 Jun; 36(23):e2311574. PubMed ID: 38433564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.